TickerFactsScreenerDevelopers

ENANTA PHARMACEUTICALS INC (ENTA) — Operating Income

Annual figures by fiscal year, from SEC filings.

2011: $25.30M2012: $21.29M2013: $9.03M2014: $18.98M2015: $124.15M2016: $30.84M2017: $24.61M2018: $88.33M2019: $36.74M2020: -$41.64M2021: -$109.57M2022: -$123.84M2023: -$137.21M2024: -$121.69M2025: -$85.35M-$85.35M
2011Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$85.35M+29.9%
2024-$121.69M+11.3%
2023-$137.21M-10.8%
2022-$123.84M-13.0%
2021-$109.57M-163.1%
2020-$41.64M-213.3%
2019$36.74M-58.4%
2018$88.33M+258.9%
2017$24.61M-20.2%
2016$30.84M-75.2%
2015$124.15M+553.9%
2014$18.98M+110.3%
2013$9.03M-57.6%
2012$21.29M-15.9%
2011$25.30M—